Polo-like kinase 1 inhibitors in human cancer therapy: development and therapeutic potential

J Zhang, L Zhang, J Wang, L Ouyang… - Journal of medicinal …, 2022 - ACS Publications
Polo-like kinase 1 (PLK1) plays an important role in a variety of cellular functions, including
the regulation of mitosis, DNA replication, autophagy, and the epithelial–mesenchymal …

Recent advances and new strategies in targeting Plk1 for anticancer therapy

KS Lee, TR Burke, JE Park, JK Bang, E Lee - Trends in pharmacological …, 2015 - cell.com
Polo-like kinase 1 (Plk1) plays key roles in regulating mitotic processes that are crucial for
cellular proliferation. Overexpression of Plk1 is tightly associated with the development of …

Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer

JM Stafford, MD Wyatt, C McInnes - Expert Opinion on Drug …, 2023 - Taylor & Francis
ABSTRACT Introduction Polo Like Kinase 1 (PLK1) is a key regulator of mitosis and its
overexpression is frequently observed in a wide variety of human cancers, while often being …

[HTML][HTML] Using ligand-mapping simulations to design a ligand selectively targeting a cryptic surface pocket of polo-like kinase 1

YS Tan, P Śledź, S Lang, CJ Stubbs… - … (International ed. in …, 2012 - ncbi.nlm.nih.gov
The treatment of protein flexibility is a major challenge in structure-based drug design
(SBDD)[1, 2] as proteins are dynamic and commonly undergo conformational changes to …

Phosphonopeptides containing free phosphonic groups: Recent advances

P Kafarski - RSC advances, 2020 - pubs.rsc.org
Phosphonopeptides are mimetics of peptides in which phosphonic acid or related
(phosphinic, phosphonous etc.) group replaces either carboxylic acid group present at C …

The emerging role of polo-like kinase 1 in epithelial-mesenchymal transition and tumor metastasis

Z Fu, D Wen - Cancers, 2017 - mdpi.com
Polo-like kinase 1 (PLK1) is a serine/threonine kinase that plays a key role in the regulation
of the cell cycle. PLK1 is overexpressed in a variety of human tumors, and its expression …

Optimized Plk1 PBD inhibitors based on poloxin induce mitotic arrest and apoptosis in tumor cells

A Scharow, M Raab, K Saxena… - ACS chemical …, 2015 - ACS Publications
Polo-like kinase 1 (Plk1) is a central regulator of mitosis and has been validated as a target
for antitumor therapy. The polo-box domain (PBD) of Plk1 regulates its kinase activity and …

The condensin component NCAPG2 regulates microtubule–kinetochore attachment through recruitment of Polo-like kinase 1 to kinetochores

JH Kim, J Shim, MJ Ji, Y Jung, SM Bong… - Nature …, 2014 - nature.com
The early event of microtubule–kinetochore attachment is a critical stage for precise
chromosome segregation. Here we report that NCAPG2, which is a component of the …

Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis

MN Peerzada, P Khan, NS Khan, A Gaur… - New Journal of …, 2020 - pubs.rsc.org
Microtubule affinity-regulating kinase 4 (MARK4) is a serine/threonine kinase involved in the
phosphorylation of MAP proteins that regulates microtubule dynamics and abets tumor …

High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells

RF Lera, ME Burkard - Journal of Biological Chemistry, 2012 - ASBMB
Protein kinases play key roles in regulating human cell biology, but manifold substrates and
functions make it difficult to understand mechanism. We tested whether we could dissect …